Pfizer to acquire Biohaven Pharma for $11.6 billion
Posted on11 May 2022
Comments0
Pfizer entered into a definitive agreement under which Pfizer will acquire Biohaven for 11.6 billion $. Biohen is the maker of Nurtec... Read More
Sun Pharma to launch Vortioxetine in India
Sun Pharma has entered into an exclusive patent licensing agreement with H. Lundbeck A/S (“Lundbeck”) to market and distribute its own version... Read More
Is HEOR and Market Access is same?
HEOR and market access are the two separate domain or functional area within pharmaceutical organization. But they work for the same or... Read More
Case Insight: Natco acquires Dash Pharmaceuticals
Posted on17 Dec 2021
Comments0
NATCO Pharma, through its affiliates, is proposing to enter into an agreement to acquire Dash Pharmaceuticals LLC subject to satisfactory completion of... Read More
Cadila launches ayurvedic energy tonic Healtherbs
Drug major Cadila Pharmaceuticals has introduced an ayurvedic general health tonic that helps keep the body young, active and fit. The key... Read More
Cipla’s social initiative to improve access to nebulisers in primary healthcare centres of rural India
Cipla Limited announced a first-of-its-kind initiative to improve access to nebulization therapy specifically for patients in the rural sections of the country.... Read More
Pharma Case Study: Merck’s $11.5B acquisition of Acceleron
Posted on03 Oct 2021
Comments0
Merck will acquire Acceleron Pharma, Inc. XLRN for $180 per share in cash for an approximate total equity value of $11.5 billion... Read More
Sanofi Bangladesh Limited’s majority stake is acquired by Beximco Pharma, Bangladesh
Beximco Pharmaceuticals Limited, one of leading pharmaceutical company based at Bangladesh, have completed its acquisition of the majority stake (54.6%) in Sanofi... Read More
What are the difference between Wholesaler and Specialty Pharmacy?
Posted on07 Sep 2021
Comments0
There are clear cut difference between the two terms. The wholesalers are the first purchaser of the drug, directly from manufacturer. Specialty... Read More
DRL enters agreement to sell its rights to anti-cancer agent E7777 to Citius Pharma
Dr Reddy’s Laboratories Ltd announced that it has entered into a definitive agreement with Citius Pharmaceuticals, Inc. pursuant to which it sold... Read More